We firmly believe in strong long-term partnerships as the core of successful drug discovery and development. Therefore, we provide these services to pharmaceutical companies, non-profit organizations and academic institutions by adopting a flexible business model that can be modulated according to your needs.

We dedicate an interdisciplinary team to advance your project from early-stage discovery (e.g. high-throughput screening or hit phase) to preclinical development, operating on a FTE-based approach. A Senior Project Leader coordinates the team and represents the perfect contact point to discuss strategies, provide scientific advice and modify approaches as needed.

For partners with different business needs, we are also happy to address specific tasks on a fee-for-service basis, or by adopting risk-sharing R&D contract agreements sharing costs, and linking downstream payments to agreed-upon milestones.